Is Lend Lease Group a blue-chip opportunity?

Lend Lease Group (ASX:LLC) is looking attractively priced and is performing well.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Global property and infrastructure company Lend Lease Group (ASX: LLC) has reported a $618.6 million profit for the financial year ending June 30, 2015.

Here's what investors need to know:

  • Profit after tax declined compared with the prior year's results which benefitted from the one-off sale of a major UK shopping centre. Profit for 2015 came in at $618.6 million which equated to 106.8 cents per share (cps)
  • A final dividend of 27 cps has been declared, taking full year distributions to 54 cps
  • The development pipeline is up 19% on the prior year to $44.9 billion
  • The group has record pre-sold revenue of $5.2 billion across residential apartments and communities – a 109% increase on the prior period
  • The construction backlog stands at $17.3 billion, up 7% year on year
  • Funds under management surged 31% to $21.3 billion

What now:

Lend Lease is something of a quiet achiever in the large cap, blue-chip space. The company's share price is up over 100% in the past five years, however on a one-year basis the stock has given up all of its early gains to be sitting roughly flat over the past 52 weeks.

With such an impressive list of operating metrics there would appear to be solid drivers of further growth in the current financial year. Management's assessment for the company's outlook is similarly upbeat.

One consensus forecast (according to data from Morningstar) for earnings per share is 119.9 cents per share, which looks achievable given the positive momentum Lend Lease appears to enjoy.

In early Monday morning trade the stock has fallen 4.6% to $13.65, implying a price-to-earnings ratio of 11.4 times, a seemingly undemanding multiple for a market-leading business such as this.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »